Pyridostigmine Bromide
Pyridostigmine Bromide Tablets
Approved
Approval ID
e756717f-941b-42f2-ba3b-03798c005ae7
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 9, 2023
Manufacturers
FDA
Method Pharmaceuticals, LLC
DUNS: 060216698
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
PYRIDOSTIGMINE BROMIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code58657-810
Application NumberANDA211181
Product Classification
M
Marketing Category
C73584
G
Generic Name
PYRIDOSTIGMINE BROMIDE
Product Specifications
Route of AdministrationORAL
Effective DateDecember 9, 2023
FDA Product Classification
INGREDIENTS (4)
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
PYRIDOSTIGMINE BROMIDEActive
Quantity: 30 mg in 1 1
Code: KVI301NA53
Classification: ACTIB